Treatment-Resistant Hypertension: Diagnosis and Management Power Over Pressure www.poweroverpressure.com.

Slides:



Advertisements
Similar presentations
Diet and Hypertension.
Advertisements

1 Accurate BP measurement in the diagnosis of hypertension Introduction to AOBP (Automated Office Blood Pressure) Mark Gelfer, MD.
SHAHKUR SHABIR GP REGISTRAR DR ELLA RUSSELL -GP TRAINER SUNNYBANK MEDICAL CENTRE OCT 2011.
The Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Internal Medicine/Pediatrics.
Treatment-Resistant Hypertension: Magnitude of the Problem Power Over Pressure
CONTROLLING YOUR RISK FACTORS Taking the Steps to a Healthy Heart.
Measuring Blood Pressure
Hypertension Blood pressure levels are a function of cardiac output multiplied by peripheral resistance (the resistance in the blood vessels to the flow.
By jamshid najafian Internist cardiologist.  Lifestyle modification is indicated for all patients with hypertension, regardless of drug therapy.  It.
Hypertension. Hypertension or high blood pressure is a chronic medical condition in which the blood pressure in the arteries is elevated. This requires.
Treatment-Resistant Hypertension: Diagnosis and Management Power Over Pressure
The British Approach to Antihypertensive Therapy: Guidelines from the National Institute of Health and Clinical Excellence Power Over Pressure
Resistant hypertension increases patients’ cardiovascular risk 30% of all treated patients develop resistant hypertension [1-5]. Resistant hypertension.
CVD risk estimation and prevention: An overview of SIGN 97.
For A Healthy Heart: Blood Pressure Management Presented by: Daniel Schimmel, MD, MS Assistant Professor of Medicine, Cardiology Bluhm Cardiovascular Institute.
Nursing 210 Advanced Cardiac UNIT 2 Laurie Brown RN, MSN, MPA-HA, CCRN.
Blood pressure measurement PHCL 326 (1+1) Clinical skills for pharmacists.
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Clinical Goals for the Healthy.
BHS Guidelines for the management of hypertension BHS IV, 2004 and Update of the NICE Hypertension Guideline, 2006 Guidelines for management of hypertension:
Blood Pressure Monitoring
Hypertension (high blood pressure) Dr. Fiona Gillan GP Registrar at Church End Medical Centre.
Diagnosis and Management of Hypertension Davin Haraway DO,FACOI,CWS Associate Professor of Medicine – OSU Center for Health Sciences.
Hypertension Dr. Meg-angela Christi Amores. Hypertension doubles the risk of cardiovascular diseases present in all populations except for a small number.
LIFESTYLE MODIFICATIONS FOR PREVENTING HEART DISEASE [e.g. HEART ATTACKS] [ primary prevention of coronary artery disease ] DR S. SAHAI MD [Med.], DM [Card]
A guide for healthcare professionals Measuring Blood Pressure at Home Michigan Department of Community Health Heart Disease and Stroke Prevention Unit.
©2007 RUSH University Medical Center Hyperuricemia in adolescents with primary hypertension: how and when to intervene? Farahnak Assadi, M.D. Professor.
Hypertension: JNC 7 Guidelines Steven W Harris MHS PA-C.
Tt HRB Centre for Health and Diet Research The burden of hypertension Ivan J Perry, Dept. of Epidemiology and Public Health, University College Cork. Institute.
Implementing NICE guidance
HYPERTENSION Objectives –Understand the importance of blood pressure –Know how to get the most out of self monitoring of blood pressure.
Assessment, Targets, Thresholds and Treatment Bryan Williams NICE clinical guideline 127.
HOME AND AMBULATORY BLOOD PRESSURE MONITORING
1 1 Individualized Therapy forHypertension Introduction to Primary Care: a course of the Center of Post Graduate Studies in FM PO Box – Riyadh
Dr. Atapour Nephrologist. Hypertension Blood pressure levels are a function of cardiac output multiplied by peripheral resistance (the resistance in.
 Edmond 75 years presented with ‘shocking” blood pressure recordings of 184/102 in the morning. His afternoon and night readings were in the ‘acceptable.
FAME HTN Mohsen. Epidemiology and stuff  About 1/3 of middle aged patients have hypertension  About ½ of elderly patients have hypertension.  Responsible.
1 Hypertension Overview. 2 Leading Risks For Death (World Health Organization 2002) Cholesterol Alcohol HYPERTENSION Tobacco use Overweight.
 Update on Hypertension Troy L. Randle, DO, FACC, FACOI.
Definitions and classification of office blood pressure levels (mmHg) Modified by ESC Guidelines 2013 CARDIOcheckAPP.
Investigations: Urine examination. Urine examination. Serum K. Serum K. Serum creatinine. Serum creatinine. Blood Sugar. Blood Sugar. Hb. Hb.
Racial, genetic, life style influence: Type extent of complications (renal failure and stroke are more common in blacks). Response to dietary therapy (low.
Hypertension NICE CG127 August Hypertension is not a disease it is a risk factor for cardiovasuclar disease (CVD)-it is a modifiable risk factor.
Hypertension: Blood Pressure Measurement and the new NICE guideline Prof Richard McManus BHS Annual Meeting Cambridge 2011 NICE clinical guideline 127.
Risk of hypertension (HTN) and non-drug management Aliakbar Tavassoli.
Hypertension Dr Nidhi Bhargava 8/10/13. Why Treat Increased risk of cardiovascular death and mortality Increased systolic, diastolic and pulse pressures.
Radka Adlová Arterial hypertension and preventive cardiology.
Hypertension Dr. Gerrard Uy. Hypertension doubles the risk of cardiovascular diseases present in all populations except for a small number of individuals.
Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.
FACTORS THAT INCREASE YOUR RISK OF DEVELOPING HIGH BLOOD PRESSURE: Family history of high blood pressure Race (African-Americans are more likely to.
Section III. Assessment of Overall Cardiovascular Risk in Hypertensive Patients 2015 Canadian Hypertension Education Program Recommendations.
Hypertension I Diagnosis, causes 1. Mean systolic and diastolic blood pressure by age for men and women Hypertension
Section I. Accurate Measurement of Blood Pressure
2015 Canadian Hypertension Education Program Recommendations
Section VII. Home BP Measurement 2015 Canadian Hypertension Education Program Recommendations.
Michelle Gardner RN NUR-224. OBJECTIVES  Define normal blood pressure and categories of abnormal pressure  Identify risk factors for hypertension 
Monday, July 25 th,  Diagnostic Evaluation  COST  Confirm the diagnosis  Organize a diagnostic approach  Determine the Severity of the HTN.
Journal Club February 7, 2014 Sadie T. Velásquez, MD.
Getting Blood Pressure To Goal: a Pressurized Process Grant M. Greenberg M.D., M.A., M.S.H.A.
1 Effect of Ramipril on the Incidence of Diabetes The DREAM Trial Investigators N Engl J Med 2006;355 FM R1 윤나리.
Resistant Hypertension - Primary Aldosteronism - 내분비 대사 내과 R3 송 란.
Resistant Hypertension Topic Discussion Brian Skinner, PharmD PGY-1 Pharmacy Resident St. Vincent Indianapolis Hospital.
Getting Blood Pressure To Goal: a Pressurized Process
Diagnosis and initial management of hypertension in primary care
BIOELECTRONICS 1 Lec10: ch4 Blood Measurements By
Defining hypertension
Nursing Care of Patients with Hypertension
Judith H. Veis, MD, FACP Associate Director, Nephrology
Hypertension Hanna K. Al-Makhamreh, MD FACC Interventional Cardiology.
Achieving the Clinical Potential of RAAS Blockade
Primary Hypertension Max C. Reif, M.D.
Presentation transcript:

Treatment-Resistant Hypertension: Diagnosis and Management Power Over Pressure

Not all patients with uncontrolled hypertension are treatment resistant Uncontrolled Hypertension Includes patients who lack blood pressure (BP) control for any reason: 1 Inadequate treatment regimens Poor adherence Undetected secondary hypertension True treatment resistance 1.Calhoun DA, et al. Circulation. 2008;117:e510-e Mancia G, et al. Eur Heart J. 2007;28: Treatment-Resistant Hypertension BP that remains above goal with maximum tolerated doses of ≥3 antihypertensive medications* of different classes; ideally, 1 of the 3 agents should be a diuretic 1,2 *Patients who require  4 antihypertensive agents to achieve BP control are also considered treatment resistant, according to some sources. 1 Power Over Pressure

Black race Excessive dietary salt ingestion Who is at risk? *Based on analyses of data from the Framingham Study and The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Calhoun DA, et al. Circulation. 2008;117:e510-e526. Obesity High baseline blood pressure Older age Chronic kidney disease Diabetes Left ventricular hypertrophy Female sex Patient Characteristics Associated With Treatment-Resistant Hypertension* Power Over Pressure

Which of these patients have treatment-resistant hypertension? Power Over Pressure

Which of these patients have treatment-resistant hypertension? Calhoun DA, et al. Circulation. 2008;117:e510-e526. Treatment-resistant hypertension is a diagnosis of exclusion, requiring a systematic approach to evaluation and management Power Over Pressure

The systematic approach to diagnosis begins with the definition… BP that remains above goal, in spite of… *All medications should be titrated to the maximum in-label doses or until BP control is achieved, except in cases of intolerance, in which case treatments should be optimized to the maximum tolerated doses † Patients who require  4 antihypertensive agents to achieve BP control are also considered treatment resistant, according to some sources. 1 1.Calhoun DA, et al. Circulation. 2008;117:e510-e Mancia G, et al. Eur Heart J. 2007;28: Treatment-resistant hypertension is defined as: 1,2 compliance with maximum doses*… of  3 antihypertensive medications † … from different classes, ideally including a diuretic… BP Goal Reversible causes identified and addressed Power Over Pressure

Treatment-resistant hypertension: a systematic approach to evaluation and management Confirm Accuracy of BP Measurement Utilize correct BP measurement technique Rule out white-coat effect Optimize Pharmacotherapy and Adherence Regimen of 3 drugs of different classes, including a diuretic Assess and improve adherence to the treatment regimen Intensify pharmacologic therapy Address Lifestyle Barriers to BP Control Interfering substances Dietary salt intake Alcohol consumption Obesity Consider Referral to a Specialist Treatment for secondary causes of hypertension Hypertension specialist for intensive management of true treatment-resistant hypertension Power Over Pressure Moser M, Setaro JF. N Engl J Med. 2006;355:

Treatment-resistant hypertension: a systematic approach to evaluation and management Confirm Accuracy of BP Measurement Utilize correct BP measurement technique Rule out white-coat effect Optimize Pharmacotherapy and Adherence Regimen of 3 drugs of different classes, including a diuretic Assess and improve adherence to the treatment regimen Intensify pharmacologic therapy Address Lifestyle Barriers to BP Control Interfering substances Dietary salt intake Alcohol consumption Obesity Consider Referral to a Specialist Treatment for secondary causes of hypertension Hypertension specialist for intensive management of true treatment-resistant hypertension Power Over Pressure Moser M, Setaro JF. N Engl J Med. 2006;355:

Technique is a common cause of pseudoresistance A cuff that is too small may cause an erroneously elevated reading 1,2 –Properly sized cuff rule-of-thumb: the cuff’s air bladder should encircle at least 80% of the patient’s arm circumference 1.Makris A, et al. Int J Hypertens.2011: Pickering T, et al. Hypertension. 2005;45: Allow patient to sit quietly for 5 minutes with the arm supported at heart level before the reading is taken 1,2 –Patient should remove clothing that constricts upper arm 2 –The average of 2 readings taken a minute apart should be recorded as the patient’s blood pressure 1 –If BP is significantly different between the 2 arms, use the higher reading to guide treatment decisions 2 Tips for obtaining accurate office BP readings Other factors that can effect BP readings include recent caffeine, nicotine, or alcohol consumption, full bladder, and background noise (including conversation) 2 Power Over Pressure

Eliminating “white-coat” effect What Is It? –Elevated BP in physician’s office, but significantly lower when measured at home 1 How Prevalent? –A recent Spanish study of 8,295 patients with treatment-resistant hypertension found that 37.5% actually had office-resistant hypertension 2 When to Suspect? –White-coat resistance may be present in patients with consistently elevated BP but no evidence of target organ damage 3 How to Screen? –Consider repeated at-home BP measurements to rule out white- coat resistance 3 –Where available, 24-hour ambulatory BP monitoring (ABPM) may be used for further diagnostic evaluation 3 Power Over Pressure 1.Calhoun D, et al. Circulation. 2008;117;e510-e de la Sierra A, et al. Hypertension. 2011;57: Moser M, Setaro JF. N Engl J Med. 2006;355:

Automated BP measurement Automated office BP measurement has several advantages 1 : Minimizes potential for user error Enables efficient collection of multiple BP readings Reduces patient anxiety and aids in detection of white-coat effect –Average of 5 BP readings taken 1 minute apart, while patient is alone in room, has been shown to approach average waking BP Home BP measurement is a useful tool: Average of as few as 6 readings may achieve similar accuracy for measurement of true ambulatory BP as ABPM 2 May improve adherence to the treatment regimen 3 Affordable and accessible 3,4 Considerations: –Patients should be trained in proper BP measurement technique 3,4 –Patients should utilize validated monitors to ensure accuracy (wrist or finger cuffs should be avoided) 3,4 –Patients should bring new devices to clinic to confirm accuracy 4 1.Myers M, et al. Hypertension. 2010;55: Chatellier G, et al. Am J Hypertens. 1996;9: Parati G, et al. J Hypertens. 2008;26: Pickering TG, White WB. J Am Soc Hypertens. 2008;2: Power Over Pressure

Power Over Pressure

Treatment-resistant hypertension: a systematic approach to evaluation and management Confirm Accuracy of BP Measurement Utilize correct BP measurement technique Rule out white-coat effect Optimize Pharmacotherapy and Adherence Regimen of 3 drugs of different classes, including a diuretic Assess and improve adherence to the treatment regimen Intensify pharmacologic therapy Address Lifestyle Barriers to BP Control Interfering substances Dietary salt intake Alcohol consumption Obesity Consider Referral to a Specialist Treatment for secondary causes of hypertension Hypertension specialist for intensive management of true treatment-resistant hypertension Power Over Pressure Moser M, Setaro JF. N Engl J Med. 2006;355:

Poor adherence is a common cause of pseudoresistance 1.Van Wijk BLG, et al. J Hypertens. 2005;23: Moser M, Setaro JF. N Engl J Med. 2006;355: Calhoun DA, et al. Circulation. 2008;117:e510-e Hill M, et al. J Clin Hypertens. 2010;12: Within just 1 year, >1 in 3 patients had already discontinued their medication 1 After 10 years, almost 2 in 3 patients did not take their antihypertensive medications continuously 1 39% Non-users 39% Continuous users 22% Restarters Percentage of patients utilizing antihypertensive agents at 10 years 1 Signs of nonadherence 2 Missed office visits Lack of physiological evidence of therapy, such as o No change in BP o Absence of anticipated common side effects Check for suspected nonadherence by Discussing medication use with spouse or caregiver 3 Verifying prescription refills with the pharmacy Reviewing factors causing nonadherence and counseling patients on importance of therapy 4 Power Over Pressure

Power Over Pressure

Treatment-resistant hypertension: a systematic approach to evaluation and management Confirm Accuracy of BP Measurement Utilize correct BP measurement technique Rule out white-coat effect Optimize Pharmacotherapy and Adherence Regimen of 3 drugs of different classes, including a diuretic Assess and improve adherence to the treatment regimen Intensify pharmacologic therapy Address Lifestyle Barriers to BP Control Interfering substances Dietary salt intake Alcohol consumption Obesity Consider Referral to a Specialist Treatment for secondary causes of hypertension Hypertension specialist for intensive management of true treatment-resistant hypertension Power Over Pressure Moser M, Setaro JF. N Engl J Med. 2006;355:

Interfering substances may contribute to treatment resistance Use of interfering substances Certain medications or other drugs may cause elevated BP or inhibit the effects of antihypertensive medications –Nonsteroidal anti-inflammatory drugs (NSAIDs) and cyclooxygenase-2 (COX-2) inhibitors –Sympathomimetic drugs (ephedra, phenylephrine, cocaine, amphetamines, etc) –Herbal supplements –Anabolic steroids –Appetite suppressants –Erythropoietin –Oral contraceptives Question patients about the use of interfering substances –If possible, discontinue use of these agents; otherwise, consider modifying antihypertensive therapy Calhoun DA, et al. Circulation. 2008;117:e510-e526. Moser M, Setaro JF. N Engl J Med. 2006;355: Power Over Pressure

Patient factors may contribute to treatment resistance Calhoun DA, et al. Circulation. 2008;117:e510-e526. Moser M, Setaro JF. N Engl J Med. 2006;355: Modifiable lifestyle factors High sodium intake (urinary sodium excretion >150 mmol/day) may contribute to treatment-resistant hypertension both by increasing BP directly and by blunting the BP-lowering effect of antihypertensive drugs –Elderly patients, black patients, and patients with chronic kidney disease may be more sensitive to salt intake Excessive alcohol intake of >3-4 drinks per day may also contribute to treatment- resistant hypertension Obesity is associated with more severe hypertension, requirement for increased number of antihypertensive medications, and increased likelihood of never achieving BP control –It is estimated that >40% of patients with treatment-resistant hypertension are obese Obesity Excessive dietary salt ingestion Excessive alcohol ingestion Power Over Pressure

What to expect: lifestyle modification effects on BP Chobanian AV, et al. JAMA. 2003;289: Blumenthal JA, et al. Arch Intern Med. 2000;160: Table courtesy of Hypertension Online. Accessed April 27, 2012 Modifications*Recommendation Approximate SBP Reduction Reduce weight Maintain normal body weight (BMI of kg/m 2 ) 3-20 mm Hg Adopt DASH diet Rich in fruit, vegetables, and low-fat dairy; reduced saturated and total fat content 8-14 mm Hg Reduce dietary sodium<100 mmol (2.4 g)/day2-8 mm Hg Increase physical activity Aerobic activity >30 min/day, most days of the week 4-9 mm Hg Moderate alcohol consumption Men: ≤2 drinks/day Women: ≤1 drink/day 2-4 mm Hg *Combining  2 of these modifications may or may not have an additive effect on blood pressure reduction. SBP = systolic blood pressure; BMI = body mass index; DASH = Dietary Approaches to Stop Hypertension. Power Over Pressure

Treatment-resistant hypertension: a systematic approach to evaluation and management Confirm Accuracy of BP Measurement Utilize correct BP measurement technique Rule out white-coat effect Optimize Pharmacotherapy and Adherence Regimen of 3 drugs of different classes, including a diuretic Assess and improve adherence to the treatment regimen Intensify pharmacologic therapy Address Lifestyle Barriers to BP Control Interfering substances Dietary salt intake Alcohol consumption Obesity Consider Referral to a Specialist Treatment for secondary causes of hypertension Hypertension specialist for intensive management of true treatment-resistant hypertension Power Over Pressure Moser M, Setaro JF. N Engl J Med. 2006;355:

Difficult-to-control hypertension may be due to underlying conditions A number of medical conditions may contribute to hypertension Patients should be screened for these disorders if suggestive findings are identified upon history taking, physical exam, or basic laboratory testing Patients with treatment-resistant hypertension and a secondary cause will rarely achieve BP control until the underlying cause is treated* Consider consultation with a hypertension specialist for evaluation of secondary causes of hypertension *Many patients with renal artery stenosis or aldosteronism may achieve BP control without diagnosis of the underlying condition. Calhoun DA, et al. Circulation. 2008;117:e510-e526. Moser M, Setaro JF. N Engl J Med. 2006;355: Kaplan NM, Victor R. Kaplan's Clinical Hypertension. 10th ed. Philadelphia, PA: Lippincott Williams & Wilkins, Secondary CauseEst Prevalence (%) Renal artery disease Aldosteronism (higher in recent series) Renal parenchymal disease (depends on Cr level) Hyperthyroidism or hypothyroidism Coarctation of the aorta<1.0 Cushing’s syndrome<0.5 Pheochromocytoma<0.5 Power Over Pressure

Summary: diagnosis and management of treatment-resistant hypertension Identify and reverse “pseudoresistance” –Confirm proper measurement technique –Exclude “white-coat” effect –Assess adherence to treatment regimen Identify and reverse factors contributing to true resistance –Interfering substances –Modifiable lifestyle factors Obesity Excessive sodium intake Excessive alcohol intake Identify and, if possible, reverse causes of secondary hypertension –Consider consultation with a hypertension specialist for evaluation of secondary causes of hypertension The diagnosis and management of true treatment-resistant hypertension is accomplished through a process of exclusion Power Over Pressure